813 related articles for article (PubMed ID: 19052996)
1. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].
Geldmacher H; Biller H; Herbst A; Urbanski K; Allison M; Buist AS; Hohlfeld JM; Welte T
Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
[TBL] [Abstract][Full Text] [Related]
3. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.
Buist AS; Vollmer WM; McBurnie MA
Int J Tuberc Lung Dis; 2008 Jul; 12(7):703-8. PubMed ID: 18544191
[TBL] [Abstract][Full Text] [Related]
4. [Prevalence of COPD in Iceland--the BOLD study].
Benediktsdóttir B; Gudmundsson G; Jörundsdóttir KB; Vollmer W; Gíslason T
Laeknabladid; 2007 Jun; 93(6):471-7. PubMed ID: 17541146
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
Stav D; Raz M
Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiologic analysis of COPD in Guangdong province].
Liu SM; Wang XP; Wang DL; Zhou YM; Lü JC; Zheng JP; Zhong NS; Ran PX
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):747-52. PubMed ID: 15949380
[TBL] [Abstract][Full Text] [Related]
8. Is COPD a rare disease? Prevalence and identification rates in smokers aged 40 years and over within general practice in Germany.
Gingter C; Wilm S; Abholz HH
Fam Pract; 2009 Feb; 26(1):3-9. PubMed ID: 19033180
[TBL] [Abstract][Full Text] [Related]
9. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study.
Maleki-Yazdi MR; Lewczuk CK; Haddon JM; Choudry N; Ryan N
COPD; 2007 Dec; 4(4):313-20. PubMed ID: 18027158
[TBL] [Abstract][Full Text] [Related]
10. The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study.
Hansen JG; Pedersen L; Overvad K; Omland Ø; Jensen HK; Sørensen HT
COPD; 2008 Dec; 5(6):347-52. PubMed ID: 19353348
[TBL] [Abstract][Full Text] [Related]
11. COPD in Japan: the Nippon COPD Epidemiology study.
Fukuchi Y; Nishimura M; Ichinose M; Adachi M; Nagai A; Kuriyama T; Takahashi K; Nishimura K; Ishioka S; Aizawa H; Zaher C
Respirology; 2004 Nov; 9(4):458-65. PubMed ID: 15612956
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B
Respiration; 2005; 72(5):471-9. PubMed ID: 16210885
[TBL] [Abstract][Full Text] [Related]
13. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease].
Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J
Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
[TBL] [Abstract][Full Text] [Related]
16. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.
Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958
[TBL] [Abstract][Full Text] [Related]
17. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
[TBL] [Abstract][Full Text] [Related]
19. Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada.
Tan WC; Bourbeau J; FitzGerald JM; Cowie R; Chapman K; Hernandez P; Buist SA; Sin DD
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1691-8. PubMed ID: 22118181
[TBL] [Abstract][Full Text] [Related]
20. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.
Ekberg-Aronsson M; Pehrsson K; Nilsson JA; Nilsson PM; Löfdahl CG
Respir Res; 2005 Aug; 6(1):98. PubMed ID: 16120227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
